Anika Therapeutics Inc
ANIK8.610USD
-0.030-0.35%
Horário de mercado （ET）Cotações atrasadas em 15 min
124.14MValor de mercado
PerdaP/L TTM
Mais detalhes de Anika Therapeutics Inc Empresa
Anika Therapeutics, Inc. is a global joint preservation company. The Company creates and delivers advancements in early intervention orthopedic care, including in the areas of osteoarthritis (OA) pain management, regenerative solutions, and sports medicine. It is focused on developing, manufacturing and commercializing products on its hyaluronic acid (HA), technology platform. Its OA Pain Management product family consists of Monovisc and Orthovisc, its injectable, HA, OA Pain Management offerings are indicated to provide pain relief from osteoarthritis conditions; and Cingal, its novel, next generation, single-injection OA Pain Management product consisting of its proprietary cross-linked HA material combined with a steroid. Its Joint Preservation and Restoration product family consists of its portfolio of orthopedic regenerative solutions products utilizing HA, including Integrity, its new hyaluronic acid-based scaffold for rotator cuff and other tendon repairs.
Informações da empresa
Código da empresaANIK
Nome da EmpresaAnika Therapeutics Inc
Data de listagemMay 16, 1985
CEODr. Cheryl Renee Blanchard, Ph.D.
Número de funcionários288
Tipo de títulosOrdinary Share
Fim do ano fiscalMay 16
Endereço32 Wiggins Ave
CidadeBEDFORD
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal01730-2315
Telefone17814579000
Sitehttps://anika.com/
Código da empresaANIK
Data de listagemMay 16, 1985
CEODr. Cheryl Renee Blanchard, Ph.D.
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Glenn R. Larsen, Ph.D.
Dr. Glenn R. Larsen, Ph.D.
Independent Director
Independent Director
50.26K
+39.24%
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
39.84K
+55.16%
Mr. William R. (Bill) Jellison
Mr. William R. (Bill) Jellison
Independent Director
Independent Director
23.10K
+158.45%
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Independent Director
Independent Director
20.40K
+227.02%
Mr. Stephen D. (Steve) Griffin
Mr. Stephen D. (Steve) Griffin
Chief Financial Officer, Chief Operating Officer, Executive Vice President
Chief Financial Officer, Chief Operating Officer, Executive Vice President
9.07K
--
Mr. Matt Hall
Mr. Matt Hall
Director, Corporate Development and Investor Relations
Director, Corporate Development and Investor Relations
--
--
Mr. Ian McLeod
Mr. Ian McLeod
Chief Accounting Officer, Vice President, Treasurer
Chief Accounting Officer, Vice President, Treasurer
--
--
Mr. Gary P. Fischetti
Mr. Gary P. Fischetti
Independent Director
Independent Director
--
--
Dr. Cheryl Renee Blanchard, Ph.D.
Dr. Cheryl Renee Blanchard, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. David B. Colleran, J.D.
Mr. David B. Colleran, J.D.
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Glenn R. Larsen, Ph.D.
Dr. Glenn R. Larsen, Ph.D.
Independent Director
Independent Director
50.26K
+39.24%
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
39.84K
+55.16%
Mr. William R. (Bill) Jellison
Mr. William R. (Bill) Jellison
Independent Director
Independent Director
23.10K
+158.45%
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Independent Director
Independent Director
20.40K
+227.02%
Mr. Stephen D. (Steve) Griffin
Mr. Stephen D. (Steve) Griffin
Chief Financial Officer, Chief Operating Officer, Executive Vice President
Chief Financial Officer, Chief Operating Officer, Executive Vice President
9.07K
--
Mr. Matt Hall
Mr. Matt Hall
Director, Corporate Development and Investor Relations
Director, Corporate Development and Investor Relations
--
--
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
OEM Channel
14.91M
56.97%
Commercial Channel
11.26M
43.03%
Por RegiãoUSD
Nome
Receita
Proporção
United States
16.36M
62.53%
Europe
5.80M
22.16%
Other
4.01M
15.31%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
OEM Channel
14.91M
56.97%
Commercial Channel
11.26M
43.03%
Distribuição de ações
Atualizado em: sáb, 17 de mai
Atualizado em: sáb, 17 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Trigran Investments, Inc.
14.16%
Caligan Partners, LP
9.95%
BlackRock Institutional Trust Company, N.A.
6.64%
The Vanguard Group, Inc.
5.39%
Dimensional Fund Advisors, L.P.
4.26%
Other
59.59%
Investidores
Investidores
Proporção
Trigran Investments, Inc.
14.16%
Caligan Partners, LP
9.95%
BlackRock Institutional Trust Company, N.A.
6.64%
The Vanguard Group, Inc.
5.39%
Dimensional Fund Advisors, L.P.
4.26%
Other
59.59%
Tipos de investidores
Investidores
Proporção
Hedge Fund
37.47%
Investment Advisor/Hedge Fund
27.11%
Investment Advisor
23.49%
Individual Investor
4.91%
Research Firm
1.57%
Pension Fund
0.77%
Bank and Trust
0.12%
Insurance Company
0.03%
Other
4.53%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
302
13.69M
95.46%
-1.42M
2025Q1
310
13.52M
94.22%
-1.59M
2024Q4
308
13.33M
91.05%
-2.02M
2024Q3
309
13.98M
94.53%
-1.95M
2024Q2
313
14.09M
95.06%
-2.05M
2024Q1
312
14.07M
96.09%
-1.66M
2023Q4
314
13.84M
94.50%
-1.88M
2023Q3
309
13.57M
92.73%
-2.13M
2023Q2
310
13.73M
93.04%
-2.32M
2023Q1
326
13.65M
93.27%
-2.92M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Trigran Investments, Inc.
2.04M
14.24%
+20.07K
+0.99%
Mar 31, 2025
Caligan Partners, LP
1.44M
10.01%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
957.43K
6.68%
-49.29K
-4.90%
Mar 31, 2025
The Vanguard Group, Inc.
777.40K
5.42%
+12.13K
+1.59%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
613.97K
4.28%
-43.38K
-6.60%
Mar 31, 2025
Acadian Asset Management LLC
539.61K
3.76%
+63.90K
+13.43%
Mar 31, 2025
Boothbay Fund Management, LLC
529.50K
3.69%
--
--
Mar 31, 2025
Renaissance Technologies LLC
528.62K
3.69%
+100.00
+0.02%
Mar 31, 2025
BlackRock Financial Management, Inc.
522.01K
3.64%
+11.71K
+2.30%
Mar 31, 2025
Alta Fundamental Advisers LLC
470.97K
3.28%
-229.46K
-32.76%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
Invesco NASDAQ Future Gen 200 ETF
0.43%
Royce Quant Small-Cap Quality Value ETF
0.15%
SPDR SSGA US Small Cap Low Volatility Index ETF
0.1%
iShares Micro-Cap ETF
0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
Avantis US Small Cap Equity ETF
0.02%
ProShares Hedge Replication ETF
0.01%
Global X Russell 2000 ETF
0.01%
ProShares UltraPro Russell2000
0.01%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.01%
Ver Mais
Invesco NASDAQ Future Gen 200 ETF
Proporção0.43%
Royce Quant Small-Cap Quality Value ETF
Proporção0.15%
SPDR SSGA US Small Cap Low Volatility Index ETF
Proporção0.1%
iShares Micro-Cap ETF
Proporção0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporção0.02%
Avantis US Small Cap Equity ETF
Proporção0.02%
ProShares Hedge Replication ETF
Proporção0.01%
Global X Russell 2000 ETF
Proporção0.01%
ProShares UltraPro Russell2000
Proporção0.01%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
Proporção0.01%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
